Related Experiment Video
Updated: Jun 3, 2026
08:51
Magnetic Resonance Imaging of Multiple Sclerosis at 7.0 Tesla
Published on: February 19, 2021
Progressive multiple sclerosis and gray matter pathology: an MRI perspective.
Matilde Inglese1, Niels Oesingmann, Patrizia Casaccia
1Department of Neurology, Mount Sinai School of Medicine, New York, NY, USA. matilde.inglese@mssm.edu
The Mount Sinai Journal of Medicine, New York
|March 23, 2011
Summary
Advanced magnetic resonance imaging (MRI) offers improved detection of brain damage in progressive multiple sclerosis (MS). These techniques are more sensitive to gray matter damage than conventional MRI, aiding diagnosis and monitoring.
Area of Science:
- Neurology
- Radiology
- Neuroimaging
Background:
- Progressive multiple sclerosis (MS) involves increasing cortical demyelination and atrophy.
- Conventional magnetic resonance imaging (MRI) aids MS diagnosis and treatment monitoring but has limitations in sensitivity and specificity for diffuse and gray matter damage.
- Advanced MRI techniques show promise in overcoming these limitations.
Purpose of the Study:
- To review brain and spinal cord imaging in MS, focusing on gray matter.
- To discuss the clinical implications of gray matter damage in MS.
- To outline current and future developments in high and ultrahigh field strength MRI for MS.
Main Methods:
- Review of brain and spinal cord imaging studies in multiple sclerosis.
- Emphasis on gray matter imaging in primary progressive MS and secondary progressive MS.
- Discussion of advanced MRI techniques and their application at high and ultrahigh magnetic field strengths.
Main Results:
- Advanced MRI techniques provide markers more specific to pathological substrates.
- These techniques are more sensitive to occult brain tissue damage in MS patients.
- Gray matter damage has significant clinical implications in progressive MS.
Conclusions:
- Advanced MRI techniques are crucial for a more comprehensive understanding of MS pathology.
- Focusing on gray matter imaging offers new insights into disease progression.
- Future developments in ultrahigh field MRI hold potential for improved MS assessment.
Related Concept Videos
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:27Imaging Studies IV: Magnetic Resonance Imaging
Introduction:Magnetic Resonance Imaging, or MRI, can include a specialized imaging technique of the urinary system known as Magnetic Resonance Urography (MRU). This radiation-free technique uses strong magnetic fields and radio waves to produce detailed images with the help of a computer. MRU is particularly effective for visualizing fluid-filled structures like the kidneys, ureters, and bladder.Applications of MRI in the Genitourinary SystemKidneys and Ureters: MRI detects tumors, cysts,...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Magnetic Resonance Imaging
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...